Syndactyly type 2

0

Syndactyly type 2 is a congenital anomaly characterized by the fusion of two or more fingers or toes. Unlike syndactyly type 1, which involves only the skin between the fingers, syndactyly type 2 also involves bone and/or joint changes. The disorder can range in severity from mild cases with minimal deformity to more severe cases involving a common phalanx. Syndactyly type 2 is often associated with other anomalies and genetic syndromes, making it an important subject of study in medical genetics and pediatrics.

History of the disease and interesting historical facts

Syndactyly has been known since ancient times; it is found in the descriptions of physicians and researchers such as Hippocrates and Avicenna. The works of these scientists contain references to various limb deformities, including syndactyly. In the mid-20th century, significant progress was made in the study of the genetic aspects of this disease. Modern research has made it possible to establish inheritance patterns of syndactyly and identify its association with certain syndromes, such as Apert syndrome and Pratt syndrome. In 1972, the genetic basis of syndactyly was first described in medical literature, which made it possible to clarify the diagnosis and treatment of this condition.

Epidemiology

Syndactyly has an incidence of 1 in 2,000 to 2,500 live births, according to various sources. It shows significant variations in prevalence depending on geographic location and ethnicity. For example, some studies report that the incidence of syndactyly is higher in people of East Asian descent. There is also evidence of gender differences: syndactyly is more common in men than in women, with a ratio of approximately 3:1. Syndactyly can be either isolated or part of more complex hereditary syndromes, which affects its prevalence in the population.

Genetic predisposition to this disease

Genetic studies show that syndactyly type 2 has a complex hereditary nature. The leading genes involved include GAS6, ZFHX3 and several others that are deviated in different cases of syndactyly. The main mutations that cause syndactyly belong to a class of chromosomal abnormalities and can be either dominant or recessive. Familial cases show the possibility of inheritance of the disease, however, in some cases syndactyly can occur sporadically with no apparent family history.

Risk factors for the development of this disease

Risk factors for syndactyly can be both genetic and exogenous. The main physical risk factors include:

  • history of syndromes with congenital anomalies;
  • hereditary predisposition;
  • age of parents, especially mother, exceeding 35 years.

Chemical risk factors include exposure to certain teratogenic substances, such as antiepileptic and antidepressant drugs, and exposure to radiation during pregnancy. Environmental studies show that environmental pollution may also have an impact on the occurrence of congenital anomalies, including syndactyly.

Diagnosis of this disease

Diagnosis of syndactyly type 2 is based on a comprehensive approach. The main symptoms include:

  • obvious fusion of fingers;
  • change in the shape and length of the fingers;
  • limited mobility in fused fingers.

Laboratory tests are also used for diagnosis, including genetic testing to identify mutations associated with the disease. Radiological tests, such as X-rays, can evaluate anatomical changes in the finger bones. Differential diagnosis includes ruling out other congenital anomalies, such as polydactyly and various forms of dysplasia.

Treatment

Treatment of syndactyly type 2 depends largely on the severity of the disease and the presence of associated anomalies. In most cases, surgery is required to separate the fused fingers. Surgery is usually performed between the ages of 1 and 3 years, when the child is more amenable to recovery. Surgery may be preceded by conservative therapy aimed at improving mobility and development of the fingers. Pharmacological treatment is used mainly to relieve pain after surgery. In some cases, physical therapy is considered to improve the functionality of the arm or leg.

List of medications used to treat this disease

Medicines used for treatment and rehabilitation after surgery include:

  • Paracetamol to relieve pain;
  • Ibuprofen to reduce inflammation;
  • Creams with dexpanthenol for skin healing after surgery;
  • Vitamins and mineral complexes to support overall health.

Disease monitoring

Monitoring of the patient's condition includes regular follow-up visits to specialists such as an orthopedist and pediatric surgeon. The prognosis with proper surgical treatment is generally good; most patients regain normal function of the limbs. However, complications such as re-fusion of the fingers, sensory disturbances, or functional limitations may develop, requiring additional treatment or rehabilitation.

Age-related features of the disease

Syndactyly can manifest itself in people of different ages, but it is most noticeable in infancy. In newborns, examination of the limbs allows for timely diagnosis of the disease and treatment planning. In adolescence and adulthood, the disease may be associated with psychological aspects, as patients may experience discomfort due to the appearance of their limbs. Age-related features also affect the speed of recovery and rehabilitation after surgery.

Questions and Answers

  • What is syndactyly type 2?
    Syndactyly type 2 is a congenital anomaly in which not only the skin but also the bones between the fingers of the extremities fuse.
  • What are the treatments for syndactyly type 2?
    The main method of treatment is surgery, but conservative rehabilitation methods, including physiotherapy, can also be used.
  • What are the symptoms of syndactyly type 2?
    Symptoms include fusion of the fingers, limited mobility, and changes in the shape of the fingers.
  • How is syndactyly diagnosed?
    Diagnosis includes a physical examination, x-rays, and genetic testing.
  • What is the prognosis for patients with syndactyly type 2?
    The prognosis is generally favorable with adequate surgical treatment, but complications such as re-fusion or functional impairment are possible.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.